Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

33672 Results Found

News

Blog: Analysis on drug prices fails to provide full context

In addition to being based on a very small sample size, a recently published study on hospital costs for clinician-administered drugs under Medicare Part B does not provide direct insight as to what hospitals actually pay to acquire these drugs, writes Aaron Wesolowski, vice president of policy research, analytics and strategy at AHA.
News

Survey: Premiums for employer-sponsored coverage up 4% in 2021

The average annual premium for employer-sponsored family health coverage rose 4% this year to $22,221, including employer and worker contributions, according to the latest annual survey of employer-sponsored health insurance by the Kaiser Family Foundation.
News

At international conference, hospital executives and AHA leaders share lessons on leadership, preparing for next pandemic

AHA President and CEO Rick Pollack was a featured speaker during the International Hospital Federation’s World Hospital Congress, held both virtually and in person in Barcelona. Pollack along with Melinda Estes, president and CEO at Saint Luke’s Health System and immediate past chair of the AHA Board of Trustees, shared insights from the North American perspective on leading during a crisis.
News

CMS announces automatic exception policy for MIPS individual clinicians

Due to the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will apply an automatic extreme and uncontrollable circumstances policy to all clinicians participating as individuals in the Quality Payment Program’s Merit-based Incentive Payment System for the 2021 performance period, the agency announced.
News

HHS invests in U.S. capacity to make COVID-19 molecular tests for providers

The Department of Health and Human Services will use $650 million from the American Rescue Plan Act to expand U.S. capacity to manufacture rapid molecular tests for COVID-19, which hospitals and other health care providers use to diagnose COVID-19, screen patients before surgery and confirm at-home test results.
News

Pfizer requests amended EUA to allow COVID-19 boosters for all U.S. adults

Pfizer asked the Food and Drug Administration to amend the emergency use authorization for its COVID-19 vaccine to allow all individuals age 18 and older to receive booster shots.
News

HRSA awards, announces grants to build COVID-19 vaccine confidence

The Health Resources and Services Administration awarded nine community-based organizations a portion of $77 million in American Rescue Plan Act funding to build vaccine confidence and bolster COVID-19 vaccinations in hard-hit, high-risk communities.
340B Advocacy Alliance Bulletin
Member

AHA 340B Advocacy Alliance Bulletin: Reminder to Register for AHA 340B Advocacy Alliance Call on Nov. 17

The AHA 340B Advocacy Alliance Nov. 17 at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
H-ISAC: White Reports
Member

H-ISAC TLP Green Daily Cyber Headlines November 10, 2021

H-ISAC TLP Green Daily Cyber Headlines for November 10, 2021.
Content

How Executive Leaders Can Inspire and Lead Community Investment

Community investment Series, otherwise known as place-based investment, helps create the social and physical environments that support community health over the long term.